All AbMole products are for research use only, cannot be used for human consumption.
Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus.
| Molecular Weight | 555.63 |
| CAS Number | 1488363-78-5 |
| Solubility (25°C) | DMSO ≥ 90 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Sofie Hdersdal, et al. The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition
| Related Glucagon Receptor Products |
|---|
| GLP-1R agonist
GLP-1R agonist is a potent GLP-1R (glucagon-like peptide 1 receptor) agonist, with KB of 26.3 nM for the recombinant human receptor. GLP-1R agonists play a key role in lowering glycated hemoglobin levels. It improves glycemic control and maintenance of body weight. |
| Glucagon (19-29), human
Glucagon (19-29), human is a potent and efficient inhibitor of insulin secretion. |
| Exendin-3/4 (59-86)
Exendin-3/4 (59-86) is a Exendin-4 peptide derivative. |
| HAEGTFTSDVS
HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide. |
| GLP-1(32-36)amide
GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
